Lir Therapeutics

📍 London, United Kingdom👥 10 employees💰 Last funded Aug 2024
Biotechnology Research🌐 lirtx.com
Website LinkedIn
Lir is an AI viral vector company. Our approach is to revolutionise gene therapy by tackling dose reduction, tissue targeting and immune evasion all at once through state-of-the-art AI modelling and a lab-in-the-loop screening pipeline. Using our nAAVigator AI pipeline we’re engineering viral vectors for gene therapy, starting with AAV. Our goal is to completely resurface viral vectors, enabling therapies that would be otherwise impossible.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Lir Therapeutics?
Lir Therapeutics has 1 investors on record on gritt.io.
When did Lir Therapeutics last raise funding?
The most recent investment in Lir Therapeutics recorded on gritt.io was in August 2024.
What industry is Lir Therapeutics in?
Lir Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lir Therapeutics based?
Lir Therapeutics is headquartered in London, United Kingdom.